Keyphrases
Combination Therapy
100%
Interleukin-1β
100%
Kawasaki Disease
100%
Intravenous Immunoglobulin (IVIg)
100%
Corticosteroids
100%
Functional Benefit
100%
Coronary Artery Endothelial Cells
100%
Human Coronary Artery Endothelial Cells
37%
High Dose
37%
High Mobility Group Box 1 (HMGB1)
37%
Apoptosis
25%
Interleukin-6
25%
Clinical Benefit
25%
Granulocyte Colony-stimulating Factor (G-CSF)
25%
Intravenous Immunoglobulin Therapy
25%
Intravenous Immunoglobulin Resistance
25%
Molecular Mechanism
12%
MRNA Expression
12%
Quantitative PCR
12%
Systemic Vasculitis
12%
Cytotoxic Effect
12%
Pediatric
12%
Induced Production
12%
Unknown Etiology
12%
Possible Mechanisms
12%
Protein Concentration
12%
Inflammatory Stimuli
12%
Culture Supernatant
12%
Protein Release
12%
Caspase 3/7 Activity
12%
Quantitative ELISA
12%
Anti-cytotoxic
12%
Effective Reduction
12%
Initial Combination Therapy
12%
Medicine and Dentistry
Endothelial Cell
100%
Combination Therapy
100%
Interleukin-1
100%
Immunoglobulin
100%
Kawasaki Disease
100%
Coronary Artery
100%
Drug Megadose
37%
Dexamethasone
37%
Tumor Necrosis Factor
25%
Programmed Cell Death
25%
Interleukin 6
25%
Granulocyte Colony Stimulating Factor
25%
Intravenous Immunoglobulin Therapy
25%
Messenger RNA
25%
Clinical Study
12%
Pediatrics
12%
Cytokine
12%
Cytotoxicity
12%
Enzyme Linked Immunosorbent Assay
12%
Caspase 3
12%
Real-Time Polymerase Chain Reaction
12%
Systemic Vasculitis
12%
Protein Secretion
12%
Immunology and Microbiology
Interleukin-1
100%
Coronary Artery
100%
Kawasaki Disease
100%
Intravenous Immunoglobulin
100%
Drug Megadose
37%
Dexamethasone
37%
Tumor Necrosis Factor
25%
Interleukin 6
25%
Granulocyte Colony-Stimulating Factor
25%
Intravenous Immunoglobulin Therapy
25%
ELISA
12%
Cytokine
12%
Vasculitis
12%
Caspase
12%
Supernatant
12%
Cytotoxicity
12%
Real-Time Polymerase Chain Reaction
12%
Protein Secretion
12%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Mucocutaneous Lymph Node Syndrome
100%
Immunoglobulin
100%
Dexamethasone
42%
Tumor Necrosis Factor
28%
Interleukin 6
28%
Immunotherapy
28%
Granulocyte Colony Stimulating Factor
28%
Messenger RNA
28%
Cytokine
14%
Enzyme-Linked Immunosorbent Assay
14%
Clinical Study
14%
Caspase 3
14%
Systemic Vasculitis
14%
Cytotoxicity
14%